[{"NetIncomeLoss_1_Q3_USD":-70988000.0,"NoninterestExpense_3_Q3_USD":11075000.0,"LongTermDebt_0_Q3_USD":191814000.0,"AssetsCurrent_0_Q3_USD":488864000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":12948.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":717680.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_3_Q3_USD":52.41,"NoninterestExpense_1_Q3_USD":3709000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":44073000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q3_USD":2451000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":221000.0,"InventoryFinishedGoods_0_Q3_USD":2171000.0,"InterestPaidNet_3_Q3_USD":10238000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_3_Q3_USD":1990000.0,"RestrictedCashCurrent_0_Q3_USD":2451000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":29621000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":37297000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":188046000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":2162000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":48732000.0,"ShareBasedCompensation_3_Q3_USD":59264000.0,"Assets_0_Q3_USD":607678000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":401848000.0,"LossContingencyAccrualProvision_3_Q3_USD":0.0,"CommonStockSharesIssued_0_Q3_shares":64387670.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":67987000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":12584.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":429000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":6774234.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":6774234.0,"NoninterestIncome_1_Q3_USD":85000.0,"NoninterestIncome_3_Q3_USD":578000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":830000.0,"LossContingencyLossInPeriod_3_Q3_USD":0.0,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_3_Q3_USD":1300000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":62449207.0,"AvailableForSaleSecuritiesCurrent_0_Q3_USD":3205000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":47164000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_3_Q3_USD":-1320000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_3_Q3_shares":270192.0,"DepreciationDepletionAndAmortization_3_Q3_USD":4408000.0,"CommonStockValue_0_Q3_USD":64000.0,"CostsAndExpenses_3_Q3_USD":343378000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-3694000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":220000.0,"InventoryRawMaterials_0_Q3_USD":10810000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":114608.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":42.0,"ResearchAndDevelopmentExpense_1_Q3_USD":50529000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":153170000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-10782000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":62925081.0,"CostsAndExpenses_1_Q3_USD":119346000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":62496000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q3_USD":401847000.0,"OperatingLeaseLiability_0_Q3_USD":80444.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-42000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-301000.0,"IncreaseDecreaseInOtherAccruedLiabilities_3_Q3_USD":6164000.0,"StockIssuedDuringPeriodSharesNewIssues_3_Q3_shares":1601884.0,"Liabilities_0_Q3_USD":299378000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":382869000.0,"OtherAssetsNoncurrent_0_Q3_USD":1524000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-71069000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-215591000.0,"IncreaseDecreaseInInventories_3_Q3_USD":9903000.0,"AvailableForSaleSecuritiesGrossUnrealizedLoss_3_Q3_USD":5000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":74990000.0,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_1_Q3_USD":419000000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":44073000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-188887000.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q3_USD":-42000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":-39000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":220000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":18500000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":3054000.0,"InventoryWorkInProcess_0_Q3_USD":38531000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":14389000.0,"CommonStockSharesOutstanding_0_Q3_shares":64387670.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":6394000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-111882000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-1201979000.0,"VariableLeaseCost_1_Q3_USD":600000.0,"VariableLeaseCost_3_Q3_USD":2600000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":30695000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":3676927.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":12222.0,"AccountsPayableCurrent_0_Q3_USD":8642000.0,"NetIncomeLoss_3_Q3_USD":-215510000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":35415000.0,"ReceivablesNetCurrent_0_Q3_USD":23894000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q3_USD":1695000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":97891.0,"LiabilitiesCurrent_0_Q3_USD":74058000.0,"CashEquivalentsAtCarryingValue_0_Q3_USD":367951000.0,"InterestExpenseDebt_3_Q3_USD":38814000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":930000.0,"LongTermDebtNoncurrent_0_Q3_USD":149508000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":27384000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":385320000.0,"PaymentsOfDebtIssuanceCosts_3_Q3_USD":49000.0,"AdditionalPaidInCapital_0_Q3_USD":1509994000.0,"AmortizationOfFinancingCostsAndDiscounts_3_Q3_USD":716000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q3_USD":52052000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_3_Q3_USD":138650000.0,"PreferredStockValue_0_Q3_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":42.53,"AvailableForSaleSecuritiesNoncurrent_0_Q3_USD":30692000.0,"InventoryNet_0_Q3_USD":51512000.0,"OperatingIncomeLoss_1_Q3_USD":-67294000.0,"OperatingIncomeLoss_3_Q3_USD":-204728000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":19.84,"CommonStockSharesAuthorized_0_Q3_shares":150000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":14570000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":13368.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":34164.0,"AvailableForSaleSecuritiesGrossUnrealizedGains_3_Q3_USD":6000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"IncreaseDecreaseInOtherCurrentLiabilities_3_Q3_USD":0.0,"IncreaseDecreaseInAccountsPayableTrade_3_Q3_USD":-10291000.0,"OperatingLeaseCost_3_Q3_USD":8000000.0,"OperatingLeaseCost_1_Q3_USD":2400000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":607678000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-127000.0,"DebtInstrumentCarryingAmount_0_Q3_USD":150000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":2180000.0,"StockholdersEquity_0_Q3_USD":308300000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":822000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-1.13,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-3.45,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q3_USD":385320000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":5454000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":49804000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardGross_1_Q3_USD":-1094000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":18076000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":59264000.0,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":22665000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":2979.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":6877000.0,"Ticker":"GBT","CIK":"1629137","name":"GLOBAL BLOOD THERAPEUTICS, INC.","OfficialName":"Global Blood Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"2248655788.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211104"}]